Abbott India Ltd.

Financial

	Abbott India	Alkem Laboratories	Aurobindo Pharma
Operational Metrics
Pharmaceutical Sector
Domestic Sales Growth - YoY	8.2 %	73.0 %	n/a
R&D as a % of Total Sales	0.02 %	3.5 %	4.7 %
Financials
5 yr Average ROE	30.11 %	17.38 %	13.97 %
5yr average Equity Multiplier	1.43	1.39	1.51
5yr Average Asset Turnover Ratio	1.14	0.86	0.71
5yr Avg Net Profit Margin	18.53 %	14.54 %	12.77 %
Price to Book	16.68	5.33	1.93
P/E	48.63	27.98	31.82
5yr Avg Cash Conversion Cycle	-46.68 Days	-61.46 Days	-49.62 Days
Inventory Days	45.22 Days	56.11 Days	59.62 Days
Days Receivable	19.34 Days	44.62 Days	30.33 Days
Days Payable	109.21 Days	122.42 Days	121.28 Days
5yr Average Interest Coverage Ratio	97.37	24.48	43.54
5yr Avg ROCE	38.77 %	22.76 %	16.69 %
5yr Avg Operating Profit Margin	23.42 %	18.44 %	19.28 %
5 yr average Debt to Equity	0.0	0.18	0.21
5yr CAGR Net Profit	15.41 %	6.44 %	-8.16 %
5yr Average Return on Assets	21.03 %	12.47 %	9.18 %
Shareholdings
Promoter Holding	74.99 %	53.04 %	51.82 %
Share Pledged by Promoters	0.0	0.0	17.08 %
Change in Promoter Holding (3 Yrs)	0.0	-4.1 %	-0.01 %
Change in Mutual Fund Holding (3 Yrs)	2.93 %	8.82 %	9.14 %

Business

	Abbott India	Alkem Laboratories	Aurobindo Pharma
Product Wise Break-Up	Product Wise Break-Up Anti Diabetic 42.82 Gastro Intestinal 25.46 Central Nervous System (CNS) 12.65 Hormones 11.59 Women`s health 7.48 Vitamin, Minerals & Nutrition 0 Hepatoprotectives 0 Respiratory 0 Vaccines 0 cardiovascular system 0 Derma 0 Anti-Infectives 0 Metabolic 0 Pain 0 Pharmaceutical 0 API 0 Formulations 0	Product Wise Break-Up Respiratory 0 Vaccines 0 Metabolic 0 Pain 0 cardiovascular system 0 Women`s health 0 Hepatoprotectives 0 Formulations 0 Anti Diabetic 0 Hormones 0 Derma 0 Pharmaceutical 100.0 Anti-Infectives 0 API 0 Vitamin, Minerals & Nutrition 0 Gastro Intestinal 0 Central Nervous System (CNS) 0	Product Wise Break-Up Respiratory 0 Vaccines 0 Metabolic 0 Pain 0 cardiovascular system 0 Women`s health 0 Hepatoprotectives 0 Formulations 87.25 Anti Diabetic 0 Hormones 0 Derma 0 Pharmaceutical 0 Anti-Infectives 0 Active Pharmaceutical Ingredient (API) 12.75 Vitamin, Minerals & Nutrition 0 Gastro Intestinal 0 Central Nervous System (CNS) 0
Location Wise Break-Up	Location Wise Break-Up India 98.65 Rest of the World 1.35 USA 0 Europe 0	Location Wise Break-Up USA 31.34 Rest of the World 0 India 68.66 Europe 0	Location Wise Break-Up USA 48.6 Rest of the World 15.8 India 10.0 Europe 25.6
Acute vs Chronic	Acute vs Chronic Chronic 46.0 Acute 27.0 Sub-chronic 27.0	-	-
Dosage Form Break-Up	Dosage Form Break-Up Injectable 39.89 Tablet 39.17 Liquids 15.9 Capsule 3.47 Ointment 0.27 Granules 0.23 Powder 0.19 Others 0.88	-	-
Brand Wise Break-Up	Brand Wise Break-Up Mixtard 19.93 Thyronorm 14.04 Ryzodeg 11.83 Udiliv 11.03 Novomix 9.31 Duphaston 8.88 Duphalac 6.69 Vertin 6.67 Novo Rapid 5.92 Cremaffin Plus 5.69 Claribid 0 Cremaffin 0 Similac 0 Ensure 0 Others 0.01	-	-

Abbott India Ltd.

SIGN UP FOR FREE